UTMD (Utah Medical Products Inc) Stock Analysis - Analyst Ratings

Utah Medical Products Inc (UTMD) is a publicly traded Healthcare sector company. As of May 21, 2026, UTMD trades at $64.17 with a market cap of $203.78M and a P/E ratio of 19.03. UTMD moved +0.00% today. Year to date, UTMD is +11.41%; over the trailing twelve months it is +18.35%. Its 52-week range spans $51.26 to $71.81. Rallies surfaces UTMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate UTMD?

The average price target is $0.00.

UTMD Key Metrics

Key financial metrics for UTMD
MetricValue
Price$64.17
Market Cap$203.78M
P/E Ratio19.03
EPS$3.38
Dividend Yield0.31%
52-Week High$71.81
52-Week Low$51.26
Volume0
Avg Volume0
Revenue (TTM)$37.53M
Net Income$10.85M
Gross Margin57.94%

UTMD Analyst Consensus

UTMD analyst coverage data. Average price target: $0.00.

Latest UTMD News

Recent UTMD Insider Trades

  • RICHINS PAUL O sold 700 (~$65.43K) on May 18, 2023.
  • RICHINS PAUL O sold 449 (~$40.77K) on Nov 18, 2022.
  • RICHINS PAUL O sold 161 (~$14.49K) on Nov 17, 2022.

Common questions about UTMD

What do analysts rate UTMD?
The average price target is $0.00.
Does Rallies show UTMD price targets?
Yes. Rallies tracks UTMD analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is UTMD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for UTMD. It does not provide personalized investment advice.
UTMD

UTMD